Whole Exome Sequencing of a Melanoma Patient with Acquired Resistance to MEK plus CDK4/6 Inhibition
Longitudinal biopsies from a melanoma patient who initially responded to MEK plus CDK4/6 inhibitor therapy were whole exome sequenced to identify potential resistance mutations. The biopsies included normal tissue, pre-treatment, on-treatment, and several post-resistance timepoints.
- 02/03/2018
- 6 samples
- DAC: EGAC00001000839
- Technology: Illumina HiSeq 2500
MD Anderson DAA
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
| Study ID | Study Title | Study Type |
|---|---|---|
| Other |
This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.
| ID | File Type | Size | Located in | |
|---|---|---|---|---|
| EGAF00001880019 | bam | 14.9 GB | ||
| EGAF00001880020 | bam | 21.1 GB | ||
| EGAF00001880021 | bam | 22.9 GB | ||
| EGAF00001880022 | bam | 33.6 GB | ||
| EGAF00001880023 | bam | 34.1 GB | ||
| EGAF00001880024 | bam | 24.9 GB | ||
| 6 Files (151.5 GB) | ||||